The European Molecular Genetics Quality Network (EMQN) is an internationally recognized, not-for-profit organization that provides external quality assessment (EQA) schemes for molecular genetic testing and clinical genomics laboratories worldwide. Based in the United Kingdom, EMQN plays a vital role in promoting high standards, accuracy, and consistency in genetic testing through its global network of participants and expert-led quality programmes.

​

EMQN community comprises an extensive peer group assessor base and network of key opinion leaders who are committed to regularly publishing best practice guidelines. With more than 2,500 participating labs in over 80 countries, EMQN is one of the largest and most respected providers of EQA in the field of clinical genomics and is accredited to ISO/IEC 17043, ensuring that its assessments are conducted with the highest standards of quality and impartiality.